Forgot your password?
typodupeerror
Biotech Patents

Researchers Work Around Hepatitis Drug Patent 298

Posted by kdawson
from the academia-vs.-big-pharma dept.
Several readers let us know about a pair of British researchers who found a workaround to patents covering drugs used to treat hepatitis C. The developers intend to produce a drug cheap enough to supply to people in the poorest parts of the world. The scientists found another way to bind a sugar to interferon, producing a drug they say should be as long-lasting and effective as those sold (at $14,000 for a year's supply) by patent holders Hoffman-La Roche and Schering Plough. Clinical trials could begin by 2008. The article quotes developer Sunil Shaunak of Imperial College London: "We in academic medicine can either choose to use our ideas to make large sums of money for small numbers of people, or to look outwards to the global community and make affordable medicines."
This discussion has been archived. No new comments can be posted.

Researchers Work Around Hepatitis Drug Patent

Comments Filter:

Uncompensated overtime? Just Say No.

Working...